1. Added Value of Blood Cells in Thrombin Generation Testing
   Jun Wan et al, 2021, Thrombosis and Haemostasis CrossRef
2. Treatment Resistance Risk in Patients with Newly Diagnosed Multiple Myeloma Is Associated with Blood Hypercoagulability: The ROADMAP-MM Study
   Grigorios T. Gerotziafas et al, 2022, Hemato CrossRef
3. The anticoagulation dilemma and future treatment avenues in patients with breast cancer and atrial fibrillation
   Anke C. Fender et al, 2021, International Journal of Cardiology CrossRef
4. Integrating Proteomics and Lipidomics for Evaluating the Risk of Breast Cancer Progression: A Pilot Study
   Natalia L. Starodubtseva et al, 2023, Biomedicines CrossRef
5. The procoagulant signature of cancer cells drives fibrin network formation in tumor microenvironment and impacts its quality. Implications in cancer cell migration and the resistance to anticancer agents
   Huong Chi Mai Tran et al, 2024, Thrombosis Research CrossRef
6. Acylated 1H-1,2,4-Triazol-5-amines Targeting Human Coagulation Factor XIIa and Thrombin: Conventional and Microscale Synthesis, Anticoagulant Properties, and Mechanism of Action
   Marvin Korff et al, 2020, Journal of Medicinal Chemistry CrossRef
7. Coagulation Factor Expression and Composition of Arterial Thrombi in Cancer-Associated Stroke
   Joonsang Yoo et al, 2023, Stroke CrossRef
8. Thrombin Generation and Cancer: Contributors and Consequences
   Caroline J. Reddel et al, 2019, Cancers CrossRef